🇺🇸 FDA
Patent

US 9180161

CAR peptide for homing, diagnosis and targeted therapy for pulmonary and fibrotic disorders

granted A61KA61K31/506A61K31/551

Quick answer

US patent 9180161 (CAR peptide for homing, diagnosis and targeted therapy for pulmonary and fibrotic disorders) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Grant date
Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/506, A61K31/551, A61K38/00, A61K38/08